(Q44864711)

English

S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer

scientific article published in January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

estrogen-receptor positive breast cancer

0 references

author name string

Bryant J

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Fisher B

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Gündüz N

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Costantino JP

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Emir B

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

239-253

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

https://scigraph.springernature.com/pub.10.1023/a:1006184428857

0 references

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006184428857

21 January 2018

DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006184428857

21 January 2018

Individual Comparisons by Ranking Methods

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006184428857

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006184428857

21 January 2018

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006184428857

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006184428857

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006184428857

7 January 2021

based on heuristic

inferred from DOI database lookup

1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006184428857

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006184428857

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006184428857

7 January 2021

based on heuristic

inferred from DOI database lookup

S-phase fraction is a prognostic factor in stage I breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006184428857

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the implementation of clinical DNA cytometry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006184428857

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1006184428857

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44864711&oldid=2054252517"